Piperacillin/Tazobactam Dosing
For adults with normal renal function, the standard dose is 3.375 g every 6 hours for most infections, or 4.5 g every 6 hours for nosocomial pneumonia, administered as an intravenous infusion over 30 minutes. 1
Standard Dosing in Adults with Normal Renal Function
For infections other than nosocomial pneumonia:
- Dose: 3.375 g (3 g piperacillin/0.375 g tazobactam) every 6 hours 1
- Total daily dose: 13.5 g (12 g piperacillin/1.5 g tazobactam) 1
- Duration: 7-10 days 1
For nosocomial pneumonia:
- Dose: 4.5 g (4 g piperacillin/0.5 g tazobactam) every 6 hours 1
- Total daily dose: 18 g (16 g piperacillin/2 g tazobactam) 1
- Duration: 7-14 days 1
- Must be combined with an aminoglycoside initially; continue aminoglycoside if Pseudomonas aeruginosa is isolated 1
For critically ill patients, higher doses may be required:
- 4.5 g every 6 hours is recommended for critically ill patients with intra-abdominal infections 2
- Some guidelines suggest doses up to 24 g/day in patients with augmented renal clearance 2
Extended Infusion Strategy
Extended infusion (3-4 hours) is strongly preferred over standard 30-minute infusions to optimize pharmacodynamic targets, particularly in critically ill patients or infections with less susceptible organisms. 2, 3
- Extended infusion increases the time above MIC (T>MIC), which is the critical pharmacodynamic parameter for beta-lactams 2
- Meta-analyses demonstrate improved outcomes with extended/continuous infusion in critically ill patients with sepsis 2
- This approach is especially important for organisms with higher MICs (e.g., Pseudomonas aeruginosa) 2
Dosing in Renal Impairment
Dose reduction is mandatory when creatinine clearance falls below 40 mL/min to prevent drug accumulation and neurotoxicity. 1
Specific Renal Dosing Adjustments
For CrCl 20-40 mL/min:
For CrCl <20 mL/min:
For hemodialysis patients:
- Non-nosocomial infections: 2.25 g every 12 hours 1
- Nosocomial pneumonia: 2.25 g every 8 hours 1
- Administer an additional 0.75 g after each dialysis session (hemodialysis removes 30-40% of the dose) 1, 4
- Give the dose after dialysis to facilitate directly observed therapy and avoid premature drug removal 5
For CAPD patients:
- Non-nosocomial infections: 2.25 g every 12 hours 1
- Nosocomial pneumonia: 2.25 g every 8 hours 1
- No supplemental dose needed 1
Critical Considerations in Renal Impairment
The dosing frequency should be reduced while maintaining the milligram dose per administration to preserve concentration-dependent bactericidal effects. 5
- Smaller doses may reduce drug efficacy 5
- Patients with residual renal function (CrCl >50 mL/min) may have significantly higher drug clearance even while on CRRT, requiring higher doses 3, 6
- Therapeutic drug monitoring is strongly recommended for patients on CRRT due to significant pharmacokinetic variability 3
Neurotoxicity Risk
Neurotoxicity is a significant concern in renal impairment due to drug accumulation, particularly when piperacillin levels exceed 157 mg/L in combination with tazobactam. 2, 3
- Piperacillin plasma concentrations above 157 mg/L predict neurological disorders with 97% specificity in ICU patients 2
- When the free minimum concentration to MIC ratio (fCmin/MIC) exceeds 8, approximately 50% of ICU patients develop neurological deterioration 2
- Regular monitoring of renal function is essential during therapy, especially in critically ill patients with fluctuating renal status 3
- Consider therapeutic drug monitoring 24-48 hours after starting treatment, after dosage changes, or with significant clinical changes 3
Pediatric Dosing (≥2 months, ≤40 kg)
For children 2-9 months:
For children >9 months:
- Appendicitis/peritonitis: 112.5 mg/kg every 8 hours 1
- Nosocomial pneumonia: 112.5 mg/kg every 6 hours 1
Pediatric patients >40 kg should receive adult dosing 1
Pediatric dosing in renal impairment has not been established 1